326 related articles for article (PubMed ID: 10677250)
1. Latent autoimmune thyroiditis in untreated patients with HCV chronic hepatitis: a case-control study.
Ganne-Carrie N; Medini A; Coderc E; Seror O; Christidis C; Grimbert S; Trinchet JC; Beaugrand M
J Autoimmun; 2000 Mar; 14(2):189-93. PubMed ID: 10677250
[TBL] [Abstract][Full Text] [Related]
2. Thyroid function and anti-thyroid autoantibodies in untreated children with vertically acquired chronic hepatitis C virus infection.
Indolfi G; Stagi S; Bartolini E; Salti R; de Martino M; Azzari C; Resti M
Clin Endocrinol (Oxf); 2008 Jan; 68(1):117-21. PubMed ID: 17692107
[TBL] [Abstract][Full Text] [Related]
3. Incidence of autoimmune thyroiditis in interferon-alpha treated and untreated patients with chronic hepatitis C virus infection.
Rocco A; Gargano S; Provenzano A; Nardone M; De Sanctis GM; Altavilla N; Chircu LV; Grimaldi F
Neuro Endocrinol Lett; 2001; 22(1):39-44. PubMed ID: 11335878
[TBL] [Abstract][Full Text] [Related]
4. Prevalence of HCV antibodies in autoimmune thyroid disease.
Testa A; Castaldi P; Fant V; Fiore GF; Grieco V; De Rosa A; Pazardjiklian MG; De Rosa G
Eur Rev Med Pharmacol Sci; 2006; 10(4):183-6. PubMed ID: 16910348
[TBL] [Abstract][Full Text] [Related]
5. Polyspecificity of antimicrosomal thyroid antibodies in hepatitis C virus-related infection.
Peoc'h K; Dubel L; Chazouillères O; Ocwieja T; Duron F; Poupon R; Johanet C
Am J Gastroenterol; 2001 Oct; 96(10):2978-83. PubMed ID: 11693336
[TBL] [Abstract][Full Text] [Related]
6. Islet cell and thyroid antibody prevalence in patients with hepatitis C virus infection: effect of treatment with interferon.
Piquer S; Hernández C; Enriquez J; Ross A; Esteban JI; Genescà J; Bonifacio E; Puig-Domingo M; Simó R
J Lab Clin Med; 2001 Jan; 137(1):38-42. PubMed ID: 11150022
[TBL] [Abstract][Full Text] [Related]
7. Subclinical autoimmune thyroid disorders in Egyptian patients with untreated chronic hepatitis C virus infection.
Mohran ZY; Abdel Kader NA; Abdel Moez AT; Abbas AA
J Egypt Soc Parasitol; 2010 Apr; 40(1):45-56. PubMed ID: 20503585
[TBL] [Abstract][Full Text] [Related]
8. Thyroid disorders in chronic hepatitis C.
Antonelli A; Ferri C; Pampana A; Fallahi P; Nesti C; Pasquini M; Marchi S; Ferrannini E
Am J Med; 2004 Jul; 117(1):10-3. PubMed ID: 15210382
[TBL] [Abstract][Full Text] [Related]
9. [Serum autoantibodies of patients with chronic hepatitis C and the significance thereof in infection of hepatitis C virus].
Wu CH; Xu XY; Tian GS; Yu YY
Zhonghua Yi Xue Za Zhi; 2006 Feb; 86(6):390-3. PubMed ID: 16677548
[TBL] [Abstract][Full Text] [Related]
10. Autoimmune manifestations during interferon therapy in patients with chronic hepatitis C: the hepatologist's view.
Pellicano R; Smedile A; Peyre S; Astegiano M; Saracco G; Bonardi R; Rizzetto M
Minerva Gastroenterol Dietol; 2005 Mar; 51(1):55-61. PubMed ID: 15756146
[TBL] [Abstract][Full Text] [Related]
11. Thyroid autoantibodies in autoimmune diseases.
Innocencio RM; Romaldini JH; Ward LS
Medicina (B Aires); 2004; 64(3):227-30. PubMed ID: 15239536
[TBL] [Abstract][Full Text] [Related]
12. Thyroid autoimmunity in children and adolescents with Type 1 diabetes mellitus.
Roldán MB; Alonso M; Barrio R
Diabetes Nutr Metab; 1999 Feb; 12(1):27-31. PubMed ID: 10517303
[TBL] [Abstract][Full Text] [Related]
13. Thyroid function, autoimmune thyroiditis and coeliac disease in juvenile idiopathic arthritis.
Stagi S; Giani T; Simonini G; Falcini F
Rheumatology (Oxford); 2005 Apr; 44(4):517-20. PubMed ID: 15695302
[TBL] [Abstract][Full Text] [Related]
14. Association between human leukocyte antigen (HLA) and interferon- induced thyroid diseases in four patients with HCV-related chronic hepatitis.
Labbadia G; Martocchia A; Mammarella A; Paoletti V; Rocco A; Benvenuto R; Antonella P; Rosaria D; Trabace S; Musca A; Falaschi P
Neuro Endocrinol Lett; 2005 Apr; 26(2):109-12. PubMed ID: 15855880
[TBL] [Abstract][Full Text] [Related]
15. [Extrahepatic manifestations of hepatitis C virus: the thyroid disorders].
Antonelli A; Ferri C; Fallahi P; Ferrari SM; Ghinoi A; Mascia MT; Ferrannini E
Recenti Prog Med; 2005; 96(7-8):370-81. PubMed ID: 16209121
[TBL] [Abstract][Full Text] [Related]
16. [Prevalence of rheumatic manifestations and non-organ specific autoimmunity in patients with autoimmune thyreopathy].
Benhatchi K; Lazúrová I; Kozáková D; Rovenský J
Vnitr Lek; 2010 Feb; 56(2):106-10. PubMed ID: 20329579
[TBL] [Abstract][Full Text] [Related]
17. Autoimmune thyroid disease and autoimmune rheumatic disorders: a two-sided analysis.
Lazúrová I; Benhatchi K; Rovenský J; Kozáková D; Wagnerová H; Tajtáková M; Shoenfeld Y; Macejova Z
Ann N Y Acad Sci; 2009 Sep; 1173():211-6. PubMed ID: 19758153
[TBL] [Abstract][Full Text] [Related]
18. Anti-C-reactive protein antibodies in chronic hepatitis C infection: correlation with severity and autoimmunity.
Kessel A; Elias G; Pavlotzky E; Zuckerman E; Rosner I; Toubi E
Hum Immunol; 2007 Oct; 68(10):844-8. PubMed ID: 17961773
[TBL] [Abstract][Full Text] [Related]
19. Elevated serum B-Lymphocyte activating factor (BAFF) in chronic hepatitis C virus infection: association with autoimmunity.
Toubi E; Gordon S; Kessel A; Rosner I; Rozenbaum M; Shoenfeld Y; Zuckerman E
J Autoimmun; 2006 Sep; 27(2):134-9. PubMed ID: 17029886
[TBL] [Abstract][Full Text] [Related]
20. Temporal relationship between the appearance of thyroid autoantibodies and development of destructive thyroiditis in patients undergoing treatment with two different type-1 interferons for HCV-related chronic hepatitis: a prospective study.
Mazziotti G; Sorvillo F; Stornaiuolo G; Rotondi M; Morisco F; Ruberto M; Cioffi M; Amato G; Caporaso N; Gaeta GB; Carella C
J Endocrinol Invest; 2002; 25(7):624-30. PubMed ID: 12150338
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
